Loss of function germline mutations in RAD51D in women with ovarian carcinoma.
Gynecol. Oncol., Dec;127(3):552-5 (2012)
Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma.
Transl Oncol., Aug;5(4):247-51 (2012)
E2F3b over-expression in ovarian carcinomas and in BRCA1 haploinsufficient fallopian tube epithelium.
Genes Chromosomes Cancer., Nov;51(11):1054-62 (2012)
BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
Cancer., Jul (2012)
Biomarkers of progestin therapy resistance and endometrial hyperplasia progression.
Am. J. Obstet. Gynecol., Jul;207(1):36.e1-8 (2012)
ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.
J Mol Diagn., Jul;14(4):357-66 (2012)
Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time.
J. Natl. Cancer Inst., May;104(9):642-5 (2012)
A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk.
Gynecol. Oncol., Jun;125(3):693-8 (2012)
PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.
Int. J. Gynecol. Pathol., Mar;31(2):151-159 (2012)
Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Int. J. Gynecol. Cancer., May;22(4):546-52 (2012)
Hereditary ovarian cancer: beyond the usual suspects.
Gynecol. Oncol., Feb;124(2):347-53 (2012)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Proc. Natl. Acad. Sci. U.S.A., Nov;108(44):18032-7 (2011)
An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription.
Nucleic Acids Res., Jan;40(2):499-510 (2012)
Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.
J. Clin. Oncol., Aug;29(22):3008-15 (2011)
Secondary mutations of BRCA1/2 and drug resistance.
Cancer Sci., Apr;102(4):663-9 (2011)
Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.
Neoplasia., Dec;12(12):993-1002 (2010)
Granulin: biomarker or interesting window into host/tumor biology?
Gynecol. Oncol., Jan;120(1):1-2 (2011)
BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.
Cancer Res., Sep;70(18):7155-65 (2010)
The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.
Cancer., Nov;116(22):5261-71 (2010)
Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing.
Proc. Natl. Acad. Sci. U.S.A., Jul;107(28):12629-33 (2010)